ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

PHARMACEUTICALS-A Say for the Consumer

(DO) issued a notification under the Drugs and Cosmetics Act banning "the manufacture and sale of fixed dose combinations of estrogen and progesterone (other than oral contraceptives)'' This has come in response to a Supreme Court order of November 1986, directing the DCI to conduct a public enquiry to determine whether these pharmaceutical products should be banned. Without a doubt the decision was long overdue. The issue of FP drugs has been hanging fire since 1975 when, on the basis of the World Health Organisation's findings, the DCI first issued a warning against their use for pregnancy testing and later, in June 1982, banned their manufacture and sale.

Dear reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top